Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
复制标题
DOI:
10.1038/sj.bjc.6605122
复制
发表时间:
2009-07-07
影响因子:
8.8
通讯作者:
中科院分区:
文献类型:
--
作者:
We recently identified and validated UBE2C RNA as a prognostic marker in 252 node-positive (N+) breast cancers by means of a microarray study. The aim of this study was to validate UBE2C protein as a prognostic marker in N+ breast cancer by immunohistochemistry (IHC). To this end, 92 paraffin-embedded blocks were used. The impact of UBE2C IHC value on metastasis-free survival (MFS) and overall survival (OS) was evaluated and compared with Ki-67 and Nottingham prognostic index (NPI) performances. In accordance with genomic data, UBE2C IHC had a significant impact both on MFS and OS (hazard ratio=6.79 – P=0.002; hazard ratio=7.14 – P=0.009, respectively). Akaike information criterion proved that the prognostic power of UBE2C IHC was stronger than that of Ki-67 (and close to that of NPI). Furthermore, multivariate analyses with NPI showed that, contrary to Ki-67 IHC, UBE2C IHC remained an independent factor, both for MFS (adjusted P=0.02) and OS (adjusted P=0.04). We confirmed that UBE2C protein measured by IHC could be used as a prognostic marker in N+ breast cancer. The potential predictive interest of UBE2C as a marker of proteasome activity needs further investigations.
登录
查看更多内容
影响因子:
6
作者:
Kauraniemi, P;Kuukasjärvi, T;Kallioniemi, A
通讯作者:
Kallioniemi, A
DOI:
10.1186/bcr2124
发表时间:
2008
期刊:
Breast cancer research : BCR
影响因子:
--
作者:
Wirapati P;Sotiriou C;Kunkel S;Farmer P;Pradervand S;Haibe-Kains B;Desmedt C;Ignatiadis M;Sengstag T;Schütz F;Goldstein DR;Piccart M;Delorenzi M
通讯作者:
Delorenzi M
影响因子:
3.8
作者:
Campone, Mario;Campion, Loic;Jezequel, Pascal
通讯作者:
Jezequel, Pascal
影响因子:
3.8
作者:
Deng, Shishan;Zhou, Hongying;Yang, Huijun
通讯作者:
Yang, Huijun
影响因子:
8
作者:
Wagner, KW;Sapinoso, LM;Hampton, GM
通讯作者:
Hampton, GM